NEPHROS INC (NEPH) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $7.16M | +31.7% |
| 2024 | $5.44M | -6.8% |
| 2023 | $5.83M | +11.2% |
| 2022 | $5.24M | +14.4% |
| 2021 | $4.58M | +25.7% |
| 2020 | $3.65M | -14.2% |
| 2019 | $4.25M | +71.1% |
| 2018 | $2.48M | +63.7% |
| 2017 | $1.52M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $7.16M | +31.7% |
| 2024 | $5.44M | -6.8% |
| 2023 | $5.83M | +11.2% |
| 2022 | $5.24M | +14.4% |
| 2021 | $4.58M | +25.7% |
| 2020 | $3.65M | -14.2% |
| 2019 | $4.25M | +71.1% |
| 2018 | $2.48M | +63.7% |
| 2017 | $1.52M | — |